Medical research

Psychedelic drugs: How to tell good research from bad

Research with psychedelic drugs has made a dramatic comeback amid a heady mix of softening societal attitudes, the lure of commercial opportunity, misgivings about the "war on drugs," and the desire to develop new ways to ...

Diseases, Conditions, Syndromes

Delayed intervention makes eliminating monkeypox more difficult

Vaccinations and lifestyle adjustments in at risk-populations have enabled public health authorities to gradually get a better handle on monkeypox in the U.S. However, a new study warns that it's too soon to relax.

Medical research

How a patient partnership is propelling cancer research

In the fall of 2018, cancer researcher Corrie Painter began presenting some intriguing early results from a new study on a rare and deadly cancer known as angiosarcoma. She and her fellow scientists hoped that by sharing ...

Medications

Study: Pfizer COVID pill showed no benefit in younger adults

Pfizer's COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalization and death for high-risk seniors, according to a large study published Wednesday.

page 7 from 40